Literature DB >> 33152255

The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.

Klemens Ruprecht1.   

Abstract

Introduction: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. While its exact etiology is unknown, it is generally believed that MS is caused by environmental triggers in genetically predisposed individuals. Strong and consistent evidence suggests a key role of Epstein-Barr virus (EBV), a B lymphotropic human gammaherpesvirus, in the etiology of MS. Areas covered: This review summarizes recent developments in the field of EBV and MS with a focus on potential mechanisms underlying the role of EBV in MS. PubMed was searched for the terms 'Epstein-Barr virus' and 'multiple sclerosis'. Expert opinion: The current evidence is compatible with the working hypothesis that MS is a rare complication of EBV infection. Under the premise of a causative role of EBV in MS, it needs to be postulated that EBV causes a specific, and likely persistent, change(s) that is necessarily required for the development of MS. However, although progress has been made, the nature of that change and thus the precise mechanism explaining the role of EBV in MS remain elusive. The mechanism of EBV in MS therefore is a pressing question, whose clarification may substantially advance the pathophysiological understanding, rational therapies, and prevention of MS.

Entities:  

Keywords:  Epstein-Barr virus; Multiple sclerosis; antibodies; etiology; risk factor; seropositivity; seroprevalence

Year:  2020        PMID: 33152255     DOI: 10.1080/1744666X.2021.1847642

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  7 in total

1.  G1/S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B.

Authors:  Jaime Yockteng-Melgar; Kathy Shire; Adam Z Cheng; Natasha Malik-Soni; Reuben S Harris; Lori Frappier
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

2.  Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination.

Authors:  Bardia Nourbakhsh; Christian Cordano; Carlo Asteggiano; Klemens Ruprecht; Carolin Otto; Alice Rutatangwa; Allysa Lui; Janace Hart; Eoin P Flanagan; Judith A James; Emmanuelle Waubant
Journal:  Ann Neurol       Date:  2021-03-24       Impact factor: 11.274

3.  The influence of human genetic variation on Epstein-Barr virus sequence diversity.

Authors:  Sina Rüeger; Christian Hammer; Alexis Loetscher; Paul J McLaren; Dylan Lawless; Olivier Naret; Nina Khanna; Enos Bernasconi; Matthias Cavassini; Huldrych F Günthard; Christian R Kahlert; Andri Rauch; Daniel P Depledge; Sofia Morfopoulou; Judith Breuer; Evgeny Zdobnov; Jacques Fellay
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

Review 4.  Epstein-Barr Virus and Neurological Diseases.

Authors:  Nan Zhang; Yuxin Zuo; Liping Jiang; Yu Peng; Xu Huang; Lielian Zuo
Journal:  Front Mol Biosci       Date:  2022-01-10

5.  Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: Results from a cohort study of 32,116 outpatients in Germany.

Authors:  Sven H Loosen; Corinna Doege; Sven G Meuth; Tom Luedde; Karel Kostev; Christoph Roderburg
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

Review 6.  Epstein-Barr virus and multiple sclerosis.

Authors:  Samantha S Soldan; Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2022-08-05       Impact factor: 78.297

7.  Prevention of MS Requires Intervention on the Causes of the Disease: Reconciling Genes, Epigenetics, and Epstein Barr Virus.

Authors:  Patrick K A Kearns
Journal:  Front Neurol       Date:  2022-02-22       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.